Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Return on Sales (2016 - 2025)

Tandem Diabetes Care (TNDM) has disclosed Return on Sales for 13 consecutive years, with 0.26% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales rose 26.0% year-over-year to 0.26%, compared with a TTM value of 0.28% through Dec 2025, down 18.0%, and an annual FY2025 reading of 25.89%, up 2599.0% over the prior year.
  • Return on Sales was 0.26% for Q4 2025 at Tandem Diabetes Care, up from 0.09% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.26% in Q4 2025 and bottomed at 0.73% in Q1 2023.
  • Average Return on Sales over 5 years is 0.13%, with a median of 0.09% recorded in 2024.
  • The sharpest move saw Return on Sales plummeted -65bps in 2023, then surged 51bps in 2024.
  • Year by year, Return on Sales stood at 0.05% in 2021, then tumbled by -240bps to 0.07% in 2022, then crashed by -112bps to 0.15% in 2023, then skyrocketed by 102bps to 0.0% in 2024, then soared by 9697bps to 0.26% in 2025.
  • Business Quant data shows Return on Sales for TNDM at 0.26% in Q4 2025, 0.09% in Q3 2025, and 0.22% in Q2 2025.